Deere & Company’s Immunic IMUX Stock Holding History

Deere & Company’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-142	Closed	-$655K	–	1076
2015 Q4	$655K	Buy	+142	New	+$463K	0.04%	432

Other funds holding IMUX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $46.4M AUM 13.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deere & Company's IMUX Position: Q1 2016 in Review

Deere & Company sold out of Immunic (IMUX) in Q1 2016, closing a stake of 142 shares — an estimated $655K sold.

Deere & Company first reported a position in IMUX in Q4 2015 and held it in 1 quarter. The position peaked at $655K in Q4 2015. 52 funds tracked by Wall St. Rank hold IMUX as of Q1 2016.

Deere & Company reported no remaining Immunic position as of Q1 2016 after selling out during the quarter.
Deere & Company sold 142 Immunic shares in Q1 2016, an estimated $655K.
Deere & Company first reported a position in Immunic in Q4 2015 and held it in 1 quarter.
Deere & Company's Immunic position peaked at $655K in Q4 2015.
52 funds tracked by Wall St. Rank held Immunic as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.